{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:34:50Z","timestamp":1785299690531,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005928","name":"Daiwa Securities Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005683","name":"Kyoto University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005683","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06274-8","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T13:21:12Z","timestamp":1771248072000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Determining the smallest worthwhile difference of beta-3 agonist treatment for overactive bladder: a benefit-harm trade-off study"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0109-7425","authenticated-orcid":false,"given":"Kenji","family":"Omae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Sahker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aran","family":"Tajika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noritoshi","family":"Sekido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshi A.","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"issue":"1","key":"6274_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/s0090-4295(02)02243-4","volume":"61","author":"P Abrams","year":"2003","unstructured":"Abrams P, Cardozo L, Fall M et al (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61(1):37\u201349. https:\/\/doi.org\/10.1016\/s0090-4295(02)02243-4","journal-title":"Urology"},{"issue":"2","key":"6274_CR2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.urology.2006.02.042","volume":"68","author":"Y Homma","year":"2006","unstructured":"Homma Y, Yoshida M, Seki N et al (2006) Symptom assessment tool for overactive bladder syndrome\u2013overactive bladder symptom score. Urology 68(2):318\u2013323. https:\/\/doi.org\/10.1016\/j.urology.2006.02.042","journal-title":"Urology"},{"issue":"11","key":"6274_CR3","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1111\/j.1464-410X.2008.07601.x","volume":"101","author":"KS Coyne","year":"2008","unstructured":"Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I (2008) The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int 101(11):1388\u20131395. https:\/\/doi.org\/10.1111\/j.1464-410X.2008.07601.x","journal-title":"BJU Int"},{"issue":"2","key":"6274_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.18553\/jmcp.2014.20.2.130","volume":"20","author":"KS Coyne","year":"2014","unstructured":"Coyne KS, Wein A, Nicholson S, Kvasz M, Chen CI, Milsom I (2014) Economic burden of urgency urinary incontinence in the United States: a systematic review. J Manag Care Pharm 20(2):130\u2013140. https:\/\/doi.org\/10.18553\/jmcp.2014.20.2.130","journal-title":"J Manag Care Pharm"},{"issue":"1","key":"6274_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JU.0000000000003985","volume":"212","author":"AP Cameron","year":"2024","unstructured":"Cameron AP, Chung DE, Dielubanza EJ et al (2024) The AUA\/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder. J Urol 212(1):11\u201320. https:\/\/doi.org\/10.1097\/JU.0000000000003985","journal-title":"J Urol"},{"key":"6274_CR6","unstructured":"The Japanese Continence Society and the Japanese Urological Association. Clinical Guidelines for Overactive Bladder Syndrome 3rd Edition. (in Japanese) http:\/\/japanese-continence-society.kenkyuukai.jp\/images\/sys\/information\/20221004153031-5AE38BBCAB689D6F748E8B038251EF44EBE396B12DA7B8074DE44A39CC6A3914.pdf [Last accessed: November 13, 2025]"},{"issue":"1","key":"6274_CR7","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s00345-025-05849-1","volume":"43","author":"K Omae","year":"2025","unstructured":"Omae K, Sekido N, Haga N et al (2025) Unsupervised machine learning approach to interpret complex lower urinary tract symptoms and their impact on quality of life in adult women. World J Urol 43(1):474. https:\/\/doi.org\/10.1007\/s00345-025-05849-1","journal-title":"World J Urol"},{"key":"6274_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12996","author":"AS Wagg","year":"2017","unstructured":"Wagg AS, Foley S, Peters J, Nazir J, Kool-Houweling L, Scrine L (2017) Persistence and adherence with mirabegron vs antimuscarinics in overactive bladder: Retrospective analysis of a UK General Practice prescription database. Int J Clin Pract. https:\/\/doi.org\/10.1111\/ijcp.12996","journal-title":"Int J Clin Pract"},{"issue":"3","key":"6274_CR9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jclinepi.2011.06.018","volume":"65","author":"ML Ferreira","year":"2012","unstructured":"Ferreira ML, Herbert RD, Ferreira PH et al (2012) A critical review of methods used to determine the smallest worthwhile effect of interventions for low back pain. J Clin Epidemiol 65(3):253\u2013261. https:\/\/doi.org\/10.1016\/j.jclinepi.2011.06.018","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"6274_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjment-2023-300919","volume":"27","author":"E Sahker","year":"2024","unstructured":"Sahker E, Furukawa TA, Luo Y et al (2024) Estimating the smallest worthwhile difference of antidepressants: a cross-sectional survey. BMJ Ment Health 27(1):e300919. https:\/\/doi.org\/10.1136\/bmjment-2023-300919","journal-title":"BMJ Ment Health"},{"issue":"2","key":"6274_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jphys.2025.02.012","volume":"71","author":"A Salame","year":"2025","unstructured":"Salame A, Ferreira ML, Hansford HJ et al (2025) The smallest worthwhile effect of surgery versus non-surgical treatments for sciatica: a benefit-harm trade-off study. J Physiother 71(2):125\u2013131. https:\/\/doi.org\/10.1016\/j.jphys.2025.02.012","journal-title":"J Physiother"},{"key":"6274_CR12","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.2025.10453","author":"E Sahker","year":"2025","unstructured":"Sahker E, Luo Y, Omae K et al (2025) Estimating the Smallest Worthwhile Difference (SWD) of Recommended Psychotherapies for Depression: An Observational Study. Br J Psychiatry. https:\/\/doi.org\/10.1192\/bjp.2025.10453. (Epub ahead of print)","journal-title":"Br J Psychiatry"},{"issue":"5","key":"6274_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13937","volume":"75","author":"J Frankel","year":"2021","unstructured":"Frankel J, Varano S, Staskin D, Shortino D, Jankowich R, Mudd PN Jr. (2021) Vibegron improves quality-of-life measures in patients with overactive bladder: patient-reported outcomes from the EMPOWUR study. Int J Clin Pract 75(5):e13937. https:\/\/doi.org\/10.1111\/ijcp.13937","journal-title":"Int J Clin Pract"},{"issue":"5","key":"6274_CR14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/bju.15020","volume":"125","author":"M Yoshida","year":"2020","unstructured":"Yoshida M, Takeda M, Gotoh M et al (2020) Efficacy of vibegron, a novel \u03b23-adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: post hoc analysis of a randomized, placebo-controlled, double-blind, comparative phase 3 study. BJU Int 125(5):709\u2013717. https:\/\/doi.org\/10.1111\/bju.15020","journal-title":"BJU Int"},{"issue":"3","key":"6274_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1370\/afm.240363","volume":"23","author":"K Ie","year":"2025","unstructured":"Ie K, Machino R, Albert SM et al (2025) Proactive deprescribing among older adults with polypharmacy: barriers and enablers. Ann Fam Med 23(3):207\u2013213. https:\/\/doi.org\/10.1370\/afm.240363","journal-title":"Ann Fam Med"},{"issue":"12","key":"6274_CR16","doi-asserted-by":"publisher","DOI":"10.2196\/42941","volume":"24","author":"D Wu","year":"2022","unstructured":"Wu D, Lowry PB, Zhang D, Tao Y (2022) Patient trust in physicians matters-understanding the role of a mobile patient education system and patient-physician communication in improving patient adherence behavior: field study. J Med Internet Res 24(12):e42941. https:\/\/doi.org\/10.2196\/42941","journal-title":"J Med Internet Res"},{"issue":"1","key":"6274_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-07172-y","volume":"21","author":"N Oguro","year":"2021","unstructured":"Oguro N, Suzuki R, Yajima N et al (2021) The impact that family members\u2019 health care experiences have on patients\u2019 trust in physicians. BMC Health Serv Res 21(1):1122. https:\/\/doi.org\/10.1186\/s12913-021-07172-y","journal-title":"BMC Health Serv Res"},{"key":"6274_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-5-64","volume":"5","author":"E Dugan","year":"2005","unstructured":"Dugan E, Trachtenberg F, Hall MA (2005) Development of abbreviated measures to assess patient trust in a physician, a health insurer, and the medical profession. BMC Health Serv Res 5:64. https:\/\/doi.org\/10.1186\/1472-6963-5-64","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"6274_CR19","first-page":"28","volume":"4","author":"J Busner","year":"2007","unstructured":"Busner J, Targum SD (2007) The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont) 4(7):28\u201337","journal-title":"Psychiatry (Edgmont)"},{"issue":"2","key":"6274_CR20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/nau.22951","volume":"36","author":"N Noguchi","year":"2017","unstructured":"Noguchi N, Chan L, Cumming RG et al (2017) <article-title update=\"added\">Natural history of non\u2010neurogenic overactive bladder and urinary incontinence over 5 years in community\u2010dwelling older men: the concord health and aging in men project. Neurourol Urodyn 36(2):443\u2013448. https:\/\/doi.org\/10.1002\/nau.22951","journal-title":"Neurourol Urodyn"},{"issue":"8","key":"6274_CR21","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/nau.21093","volume":"30","author":"S Heidler","year":"2011","unstructured":"Heidler S, Mert C, Temml C, Madersbacher S (2011) The natural history of the overactive bladder syndrome in females: a long-term analysis of a health screening project. Neurourol Urodyn 30(8):1437\u20131441. https:\/\/doi.org\/10.1002\/nau.21093","journal-title":"Neurourol Urodyn"},{"key":"6274_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.urology.2017.04.016","volume":"106","author":"S Herschorn","year":"2017","unstructured":"Herschorn S, Chapple CR, Snijder R, Siddiqui E, Cardozo L (2017) Could reduced fluid intake cause the placebo effect seen in overactive bladder clinical trials? Analysis of a large Solifenacin integrated database. Urology 106:55\u201359. https:\/\/doi.org\/10.1016\/j.urology.2017.04.016","journal-title":"Urology"},{"issue":"5","key":"6274_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003781.pub3","volume":"5","author":"A Stoniute","year":"2023","unstructured":"Stoniute A, Madhuvrata P, Still M, Barron-Millar E, Nabi G, Omar MI (2023) Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults. Cochrane Database Syst Rev 5(5):CD003781. https:\/\/doi.org\/10.1002\/14651858.CD003781.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"6274_CR24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.1784","volume":"7","author":"S Funada","year":"2024","unstructured":"Funada S, Luo Y, Uozumi R et al (2024) Multicomponent intervention for overactive bladder in women: a randomized clinical trial. JAMA Netw Open 7(3):e241784. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.1784","journal-title":"JAMA Netw Open"},{"issue":"6","key":"6274_CR25","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1097\/JU.0000000000001440","volume":"205","author":"YS Song","year":"2021","unstructured":"Song YS, Lee HY, Park JJ, Kim JH (2021) Persistence and adherence of anticholinergics and Beta-3 agonist for the treatment of overactive bladder: systematic review and meta-analysis, and network meta-analysis. J Urol 205(6):1595\u20131604. https:\/\/doi.org\/10.1097\/JU.0000000000001440","journal-title":"J Urol"},{"key":"6274_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ejogrb.2016.12.030","volume":"210","author":"A Martan","year":"2017","unstructured":"Martan A, Masata J, Krhut J, Zachoval R, Hanus T, Svabik K (2017) Persistence in the treatment of overactive bladder syndrome (OAB) with mirabegron in a multicenter clinical study. Eur J Obstet Gynecol Reprod Biol 210:247\u2013250. https:\/\/doi.org\/10.1016\/j.ejogrb.2016.12.030","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"6274_CR27","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s11606-021-06950-y","volume":"37","author":"R Suzuki","year":"2022","unstructured":"Suzuki R, Yajima N, Sakurai K et al (2022) Association of patients\u2019 past misdiagnosis experiences with trust in their current physician among Japanese adults. J Gen Intern Med 37(5):1115\u20131121. https:\/\/doi.org\/10.1007\/s11606-021-06950-y","journal-title":"J Gen Intern Med"},{"issue":"2","key":"6274_CR28","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1080\/10810730.2019.1587110","volume":"24","author":"S Jiang","year":"2019","unstructured":"Jiang S (2019) Pathways linking patient-centered communication to health improvement: a longitudinal study in China. J Health Commun 24(2):156\u2013164. https:\/\/doi.org\/10.1080\/10810730.2019.1587110","journal-title":"J Health Commun"},{"issue":"12","key":"6274_CR29","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/acr.25409","volume":"76","author":"R Yoshimi","year":"2024","unstructured":"Yoshimi R, Yajima N, Hidekawa C et al (2024) Effect of shared decision-making on trust in physicians in the management of Systemic Lupus Erythematosus: the trust measurement for physicians and patients with Systemic Lupus Erythematosus prospective cohort study. Arthritis Care Res (Hoboken) 76(12):1597\u20131605. https:\/\/doi.org\/10.1002\/acr.25409","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"6274_CR30","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3389\/fpsyt.2019.00475","volume":"10","author":"LC Howe","year":"2019","unstructured":"Howe LC, Leibowitz KA, Crum AJ (2019) When your doctor gets it and gets you: the critical role of competence and warmth in the patient-provider interaction. Front Psychiatry 10:475. https:\/\/doi.org\/10.3389\/fpsyt.2019.00475","journal-title":"Front Psychiatry"},{"issue":"8","key":"6274_CR31","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/s0149-2918(01)80104-1","volume":"23","author":"JA Ricci","year":"2001","unstructured":"Ricci JA, Baggish JS, Hunt TL et al (2001) <article-title update=\"added\">Coping strategies and health care\u2014seeking behavior in a US national sample of adults with symptoms suggestive of overactive bladder. Clin Ther 23(8):1245\u20131259. https:\/\/doi.org\/10.1016\/s0149-2918(01)80104-1","journal-title":"Clin Ther"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06274-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06274-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06274-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T17:08:45Z","timestamp":1771434525000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06274-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6274"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06274-8","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"KO reports consultant fees and lecture fees from Astellas Pharma and Kyorin Pharmaceutical, consultant fees from Kyowa Hakko Kirin, lecture fees from Ono Pharmaceutical, Pfizer, Nippon Shinyaku, and Kissei Pharmaceutical, outside the submitted work. AT reports personal fees from Eisai and Shionogi outside the submitted work. NS reports consultant fees from Nippon Shinyaku and lecture fees from Astellas Pharma, Kyorin Pharmaceutical, and Kissei Pharmaceutical, outside the submitted work. TAF reports personal fees from Boehringer-Ingelheim, Daiichi Sankyo, DT Axis, Micron, Shionogi, SONY and UpToDate, and a grant from DT Axis and Shionogi, outside the submitted work; In addition, TAF has a patent 7448125 and a pending patent 2022\u2013082495, and has licensed intellectual properties for Kokoro-app to DT Axis. All the other authors report no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This survey-based cross-sectional study was approved by the Ethics Committee of Fukushima Medical University (Approval No. REC 2024-173) and was conducted in accordance with the Declaration of Helsinki. All participants provided electronic consent prior to the survey.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}],"article-number":"175"}}